P15-09. The Potential Global Market Size and Public Health Value of Hypothetical HIV-1 Preventive Vaccines With Different Levels of Efficacy

Retrovirology - United Kingdom
doi 10.1186/1742-4690-6-s3-p210
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Efficacy Trials and Progress of HIV Vaccines

Journal of Cell Science & Therapy
2017English

Pneumococcal Vaccines for Children: A Global Public Health Priority

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2012English

Public Health and Preventive Medicine

JAMA - Journal of the American Medical Association
Medicine
1997English

Public Health and Preventive Medicine

Journal of Continuing Education in the Health Professions
MedicineE-learningEducation
1983English

From Vaccines to Global Health to Vaccines

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

The Value of the Public Health Nurse in Public Health and Welfare Administration

American Journal of Public Health
1921English

The Value of Vaccines

Nature Reviews Microbiology
Infectious DiseasesImmunologyMicrobiologyMicrobiology
2008English

Evolution of Public Health and Preventive Medicine in the United States.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1975English

Development of Targeted Adjuvants for HIV-1 Vaccines

AIDS Research and Therapy
VirologyMolecular MedicinePharmacology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy